个性化治疗规则的贝叶斯网络二阶段元分析,用于与隔离数据的多种治疗
Junwei Shen1, Erica Em Moodie1, Shirin Golchi1
1Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, Canada.
Statistical methods in medical research
|October 24, 2025
概括
这项研究引入了一种新的贝叶斯方法,用于创建个性化治疗计划,使用多个站点的数据,而无需共享敏感的患者信息. 这种方法提高了跨不同患者群体和环境的治疗优化.
科学领域:
- 生物统计学 生物统计学
- 医疗信息学 医疗信息学
- 临床试验设计 临床试验设计
背景情况:
- 个性化治疗规则通过根据个人数据定制疗法来优化患者的治疗结果.
- 多站点研究增加了统计能力和通用性,但面临着数据共享和每个站点不完整的治疗可用性的挑战.
研究的目的:
- 开发一种使用多站点数据估计个性化治疗规则的方法,同时保护患者的隐私.
- 解决多站点临床研究中的数据共享限制和部分治疗可用性的限制.
主要方法:
- 采用了两阶段的贝叶斯网络元分析方法.
- 该方法估计了多种治疗的个性化治疗规则,使用多个站点的数据,而不披露个人级别的数据.
- 使用模拟来验证参数估计的一致性.
主要成果:
- 拟议的方法为定义最佳个性化治疗规则的参数提供了一致的估计.
- 该方法有效地处理多站点数据,限制个人级别的数据共享.
- 这种方法适用于不是所有治疗方法在每个地点都可以使用的场景.
结论:
- 开发的贝叶斯网络元分析是估计多站点研究中个性化治疗规则的可行策略.
- 这种方法增强了优化不同患者群体和临床环境治疗的能力.
- 该方法提供了一个保护隐私的解决方案,用于利用复杂的临床试验数据.
相关概念视频
Mechanistic Models: Compartment Models in Individual and Population Analysis
244
Mechanistic models are utilized in individual analysis using single-source data, but imperfections arise due to data collection errors, preventing perfect prediction of observed data. The mathematical equation involves known values (Xi), observed concentrations (Ci), measurement errors (εi), model parameters (ϕj), and the related function (ƒi) for i number of values. Different least-squares metrics quantify differences between predicted and observed values. The ordinary least...
244
Bioequivalence Experimental Study Designs: Repeated Measures, Cross-Over, Carry-Over, and Latin Square Designs
178
Body:Bioequivalence experimental study designs play a pivotal role in testing the effectiveness of various treatments. Key among these are the repeated measures, cross-over, carry-over, and Latin square designs. In the repeated measures design, each subject receives all treatments, allowing for temporal comparisons. This type of design is useful in reducing variability but requires careful planning to avoid bias.The cross-over design, an economical method, involves sequential administration of...
178
Comparing the Survival Analysis of Two or More Groups
551
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
551
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
404
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
404
Bioequivalence Experimental Study Designs: Completely Randomized and Randomized Block Designs
221
Body:Bioequivalence experimental study designs are crucial methodologies used in evaluating and comparing the bioavailability of different drug products. These designs are categorized into various types: completely randomized, randomized block, repeated measures, cross and carry-over, and Latin square designs.Completely randomized designs involve randomly allocating treatments to all subjects participating in the experiment. This allocation is achieved by assigning unique random numbers to...
221
Combination Therapies and Personalized Medicine
5.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.9K


